InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,712.95
(
-0.28%
)
Post# of 97237
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

steeledge

Send PM Follow Ignore
Followers 77
Posts 3440
Boards Moderated 0
Alias Born 02/11/2004

steeledge

Member Level

Re: None

Monday, 10/26/2015 4:31:24 PM

Monday, October 26, 2015 4:31:24 PM

Post# of 97237
ONCS - SA author w/ 1678 followers calling for 50% near-term runup in ONCS.

OncoSec Medical: The Microcap Biotech With The Billion Dollar Immuno-Oncology Solution

http://seekingalpha.com/article/3604486-oncosec-medical-the-microcap-biotech-with-the-billion-dollar-immuno-oncology-solution

Trading with a market cap of only ~$60M, over $30M in cash, several Phase 2 clinical trials underway, impressive clinical data and the potential to revolutionize immuno-oncology treatment, I believe OncoSec is extremely undervalued and a prime acquisition target for a pharma company looking to optimize PD-1 inhibitor or other compounds efficacy. Look for the stock to rebound back to ~$100M market cap in the next couple months as investors become more familiar with the stock.

Solid DD combined with timeliness and conviction is a recipe for profits.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up